Updates in the Systemic Therapy Options for Clear Cell and Non–Clear Cell Renal Cell Carcinoma

Philippe E. Spiess; A. S. Johnstone; Eric Jonasch

doi:10.6004/jnccn.2023.5020

Updates in the Systemic Therapy Options for Clear Cell and Non–Clear Cell Renal Cell Carcinoma

Philippe E. Spiess, A. S. Johnstone, Eric Jonasch

Genitourinary Medical Oncology

Research output: Contribution to journal › Article › peer-review

Abstract

At the NCCN 2023 Annual Conference, experts reviewed clinical data on established therapies for patients with metastatic renal cell carcinoma and discussed strategies to effectively manage both clear cell and non–clear cell tumor histologies in the setting of advanced stages. Depicted through 3 separate case studies, they strategized the selection of optimal first-line and subsequent-line therapies based on the individual case study and the tumor characteristics in each.

Original language	English (US)
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	21
Issue number	55
DOIs	https://doi.org/10.6004/jnccn.2023.5020
State	Published - May 2023

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2023.5020

Cite this

@article{50dd185bcddc434f8f81f5744f3735e7,

title = "Updates in the Systemic Therapy Options for Clear Cell and Non–Clear Cell Renal Cell Carcinoma",

abstract = "At the NCCN 2023 Annual Conference, experts reviewed clinical data on established therapies for patients with metastatic renal cell carcinoma and discussed strategies to effectively manage both clear cell and non–clear cell tumor histologies in the setting of advanced stages. Depicted through 3 separate case studies, they strategized the selection of optimal first-line and subsequent-line therapies based on the individual case study and the tumor characteristics in each.",

author = "Spiess, {Philippe E.} and Johnstone, {A. S.} and Eric Jonasch",

note = "Publisher Copyright: {\textcopyright} JNCCN—Journal of the National Comprehensive Cancer Network.",

year = "2023",

month = may,

doi = "10.6004/jnccn.2023.5020",

language = "English (US)",

volume = "21",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "55",

}

TY - JOUR

T1 - Updates in the Systemic Therapy Options for Clear Cell and Non–Clear Cell Renal Cell Carcinoma

AU - Spiess, Philippe E.

AU - Johnstone, A. S.

AU - Jonasch, Eric

PY - 2023/5

Y1 - 2023/5

N2 - At the NCCN 2023 Annual Conference, experts reviewed clinical data on established therapies for patients with metastatic renal cell carcinoma and discussed strategies to effectively manage both clear cell and non–clear cell tumor histologies in the setting of advanced stages. Depicted through 3 separate case studies, they strategized the selection of optimal first-line and subsequent-line therapies based on the individual case study and the tumor characteristics in each.

AB - At the NCCN 2023 Annual Conference, experts reviewed clinical data on established therapies for patients with metastatic renal cell carcinoma and discussed strategies to effectively manage both clear cell and non–clear cell tumor histologies in the setting of advanced stages. Depicted through 3 separate case studies, they strategized the selection of optimal first-line and subsequent-line therapies based on the individual case study and the tumor characteristics in each.

UR - http://www.scopus.com/inward/record.url?scp=85164746981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85164746981&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2023.5020

DO - 10.6004/jnccn.2023.5020

M3 - Article

AN - SCOPUS:85164746981

SN - 1540-1405

VL - 21

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 55

ER -

Updates in the Systemic Therapy Options for Clear Cell and Non–Clear Cell Renal Cell Carcinoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this